Dagher Ibrahim B. bought BCLI
January 1, 2025 · Form 4 insider transaction
Dagher Ibrahim B. bought 50,000 shares of Brainstorm Cell Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderDagher Ibrahim B.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 1, 2025
Filing dateJanuary 7, 2025
Shares owned after66,849
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of restricted stock awarded under the Issuer's 2014 Global Share Option Plan. The shares of restricted stock shall vest as to (i) 50% of the award on the six-month anniversary of the date of grant and (ii) the remaining 50% of the award shall vest on the eighteenth-month anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.